TNYA Latest Press Releases

-- May 6, 2026 --

Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- April 27, 2026 --

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE -1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026 Globe Newswire 8:30 AM

-- March 11, 2026 --

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- March 9, 2026 --

Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301's Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy Globe Newswire 8:30 AM

-- March 5, 2026 --

Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics Globe Newswire 8:30 AM

-- March 2, 2026 --

Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026 Globe Newswire 4:05 PM

-- January 9, 2026 --

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software